SCHEMBL8936145

SCHEMBL8936145

O=c1cc(CCP)c2ccc(Cl)cc2[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
PARP1 P09874 1/20 0.46
LMNA P02545 4/20 0.45
GRIN2D O15399 3/20 0.43
GRIN3B O60391 3/20 0.43
GRIN1 Q05586 3/20 0.43
GRIN2A Q12879 3/20 0.43
GRIN2B Q13224 3/20 0.43
GRIN2C Q14957 3/20 0.43
GRIN3A Q8TCU5 3/20 0.43
HPGD P15428 2/20 0.43
ALDH1A1 P00352 2/20 0.43
GPR84 Q9NQS5 1/20 0.42
CA9 Q16790 2/20 0.42
CA12 O43570 1/20 0.42
DAO P14920 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8936103 0.80 TP53 (0.51) TP53SMN1; SMN2PARP1LMNAGRIN2D
SCHEMBL8936133 0.76 TP53 (0.54) TP53SMN1; SMN2PARP1LMNAGRIN2D
SCHEMBL8127333 0.75 TP53 (0.66) TP53SMN1; SMN2PARP1LMNAGRIN2D
SCHEMBL29483390 0.75 TP53 (0.66) TP53SMN1; SMN2PARP1LMNAGRIN2D
SCHEMBL8936172 0.74 SMN1; SMN2 (0.49) TP53SMN1; SMN2PARP1LMNAGRIN2D
SCHEMBL29410772 0.74 TP53 (0.70) TP53SMN1; SMN2PARP1LMNAGRIN2D
SCHEMBL2797754 0.73 TP53 (1.00) TP53SMN1; SMN2PARP1LMNAHPGD
SCHEMBL29340202 0.71 TP53 (0.66) TP53SMN1; SMN2PARP1LMNAGRIN2D
SCHEMBL8872926 0.71 TP53 (0.65) TP53SMN1; SMN2PARP1LMNAGRIN2D
SCHEMBL1775740 0.69 TNKS2 (0.44) TP53SMN1; SMN2PARP1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5510338-A ADMINISTERING TO A MAMMAL TO RELIEVE PAIN AND TO TREAT CONVULSIONS, CEREBRAL ISCHEMIC DAMAGE, AND EMESIS GUILFORD PHARMACEUTICALS INC. (US) 1996-04-23 US disclosed
US-5342946-A Phosphonoalkylquinolin-2-ones as novel antagonists of non-NMDA ionotropic excitatory amino acid receptors GUILFORD PHARMACEUTICALS INC. (US) 1994-08-30 US disclosed